Eli Lilly and Co (NYSE:LLY) over-valued by 37%
Website | https://www.lilly.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $188,458,008,576 |
Beta | 0.261996 |
Average Volume | $3,357,147 |
Last Dividend | 3.18% |
Price on Nov 1, 2022 | $352.58 |
Autochartist™ Valuation | $222.76 |
Conclusion |
37% over-valued |
Download Report |